These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 31786118)

  • 1. Urothelial Carcinoma of the Renal Pelvis and Ureter: Does Location Make a Difference?
    Lwin AA; Hsu CH; Chipollini J
    Clin Genitourin Cancer; 2020 Feb; 18(1):45-49.e1. PubMed ID: 31786118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transitional cell carcinomas of the renal pelvis and the ureter: comparative demographic characteristics, pathological grade and stage and 5-year survival in a Taiwanese population.
    Tan LB; Chang LL; Cheng KI; Huang CH; Kwan AL
    BJU Int; 2009 Feb; 103(3):312-6. PubMed ID: 18782312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephroureterectomy vs. segmental ureterectomy of clinically localized, high-grade, urothelial carcinoma of the ureter: Practice patterns and outcomes.
    Piraino JA; Snow ZA; Edwards DC; Hager S; McGreen BH; Diorio GJ
    Urol Oncol; 2020 Nov; 38(11):851.e1-851.e10. PubMed ID: 32859461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center.
    Favaretto RL; Shariat SF; Chade DC; Godoy G; Adamy A; Kaag M; Bochner BH; Coleman J; Dalbagni G
    Eur Urol; 2010 Oct; 58(4):574-80. PubMed ID: 20637540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinoma.
    Nazzani S; Mazzone E; Preisser F; Tian Z; Mistretta FA; Shariat SF; Montanari E; Acquati P; Briganti A; Saad F; Carmignani L; Karakiewicz PI
    Eur J Surg Oncol; 2019 Jul; 45(7):1238-1245. PubMed ID: 30563773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pattern and risk factors of local recurrence after nephroureterectomy for upper tract urothelial carcinoma.
    Li X; Cui M; Gu X; Fang D; Li H; Qin S; Yang K; Zhu T; Li X; Zhou L; Gao XS; Wang D
    World J Surg Oncol; 2020 May; 18(1):114. PubMed ID: 32473636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of micropapillary histological variant on survival after radical nephroureterectomy for upper tract urothelial carcinoma.
    Masson-Lecomte A; Colin P; Bozzini G; Nison L; de La Taille A; Comperat E; Zerbib M; Rozet F; Cathelineau X; Valeri A; Ruffion A; Guy L; Droupy S; Cussenot O; Rouprêt M
    World J Urol; 2014 Apr; 32(2):531-7. PubMed ID: 23907662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laparoscopic radical nephroureterectomy is associated with worse survival outcomes than open radical nephroureterectomy in patients with locally advanced upper tract urothelial carcinoma.
    Kim HS; Ku JH; Jeong CW; Kwak C; Kim HH
    World J Urol; 2016 Jun; 34(6):859-69. PubMed ID: 26497823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifocality rather than tumor location is a prognostic factor in upper tract urothelial carcinoma.
    Williams AK; Kassouf W; Chin J; Rendon R; Jacobsen N; Fairey A; Kapoor A; Black P; Lacombe L; Tanguay S; So A; Lattouf JB; Bell D; Fradet Y; Saad F; Matsumoto E; Drachenberg D; Cagiannos I; Izawa JI
    Urol Oncol; 2013 Oct; 31(7):1161-5. PubMed ID: 23415596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients.
    Lughezzani G; Jeldres C; Isbarn H; Sun M; Shariat SF; Alasker A; Pharand D; Widmer H; Arjane P; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    Eur J Cancer; 2009 Dec; 45(18):3291-7. PubMed ID: 19615885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node yield and tumor location in patients with upper tract urothelial carcinoma undergoing nephroureterectomy affects survival: A U.S. population-based analysis (2004-2012).
    Chappidi MR; Kates M; Johnson MH; Hahn NM; Bivalacqua TJ; Pierorazio PM
    Urol Oncol; 2016 Dec; 34(12):531.e15-531.e24. PubMed ID: 27476032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncologic Outcomes Following Robot-Assisted Laparoscopic Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma.
    Aboumohamed AA; Krane LS; Hemal AK
    J Urol; 2015 Dec; 194(6):1561-6. PubMed ID: 26192256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Rieken M; Schubert T; Xylinas E; Kluth L; Rouprêt M; Trinh QD; Lee RK; Al Hussein Al Awamlh B; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Bachmann A; Shariat SF;
    Eur J Surg Oncol; 2014 Dec; 40(12):1693-9. PubMed ID: 24780094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological Behavior and Long-Term Outcomes of Carcinoma In Situ in Upper Urinary Tract Managed by Radical Nephroureterectomy.
    Inamoto T; Matsuyama H; Ibuki N; Komura K; Takahara K; Fujimoto K; Shiina H; Sakano S; Nagao K; Miyake M; Tatsumi Y; Yasumoto H; Azuma H;
    J Urol; 2018 Apr; 199(4):933-939. PubMed ID: 29037861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.
    Rink M; Robinson BD; Green DA; Cha EK; Hansen J; Comploj E; Margulis V; Raman JD; Ng CK; Remzi M; Bensalah K; Kabbani W; Haitel A; Rioux-Leclercq N; Guo CC; Chun FK; Kikuchi E; Kassouf W; Sircar K; Sun M; Sonpavde G; Lotan Y; Pycha A; Karakiewicz PI; Scherr DS; Shariat SF
    J Urol; 2012 Aug; 188(2):398-404. PubMed ID: 22698626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Rieken M; Xylinas E; Kluth L; Trinh QD; Lee RK; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Kautzky-Willer A; Bachmann A; Shariat SF;
    Eur J Surg Oncol; 2014 Jan; 40(1):113-20. PubMed ID: 24113620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of chemotherapy for patients with pT3N0M0 renal pelvic urothelial carcinomas: An inverse probability of treatment weighting comparison using Surveillance, Epidemiology, and End Results data.
    Liu Z; Huang J; Li X; Huang C; Ye Y; Zhang J; Liu Z
    Cancer Med; 2020 Aug; 9(16):5756-5766. PubMed ID: 32585775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
    Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W
    BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Consequences of Inadvertent Radical Nephrectomy in the Treatment of Upper Tract Urothelial Carcinoma.
    Al Hussein Al Awamlh B; Shoag JE; Basourakos SP; Lewicki PJ; Posada L; Ma X; Raman JD; Shariat SF; Scherr D
    Urology; 2021 Aug; 154():127-135. PubMed ID: 33766715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
    Isbarn H; Jeldres C; Shariat SF; Liberman D; Sun M; Lughezzani G; Widmer H; Arjane P; Pharand D; Fisch M; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    J Urol; 2009 Nov; 182(5):2177-81. PubMed ID: 19758662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.